CDDW Abstracts 2006
Return to Main Menu
Search CDDW 2006 Abstracts
142 - PORTAL PYEMIA AS A PRESENTING FEATURE OF PEDIATRIC CROHN'S DISEASE
143 - EVALUATION OF THE RELATIONSHIP BETWEEN CLINICAL FINDINGS AND COLONOSCOPIC ASSESSMENT IN PATIENTS ...
144 - SUPERIOR INTERACTION PROFILE OF PANTOPRAZOLE VS ESOMEPRAZOLE AFTER SINGLE DOSE DIAZEPAM REGARD...
145 - MESAVANCE (SPD476), A NOVEL, ONCE-DAILY, HIGH-DOSE 5-ASA FORMULATION IS EFFECTIVE AND WELL TOL...
146 - ONCE-DAILY MESAVANCE (SPD476), A NOVEL, HIGH-STRENGTH FORMULATION OF MESALAMINE, INDUCES REM...
147 - COMPARISON OF TIME TO SYMPTOM RESOLUTION WITH ORAL MESALAMINE 4.8 G/DAY (800 MG TABLET) VERSUS ...
148 - EFFICACY AND SAFETY OF ASACOL 4.8 G/DAY (800 MG TABLET) COMPARED WITH 2.4 G/DAY (400 MG TABLET) IN ...
149 - COLORECTAL SURVEILLANCE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
150 - HEMATOPOIETIC CELL TRANSPLANTATION FOR CROHN'S DISEASE; IS IT TIME TO GO FOR A CURE?
151 - SARGRAMOSTIM IMPROVES QUALITY OF LIFE AS MEASURED BY THE INFLAMMATORY BOWEL DISEASE QUESTION...
152 - QUALITY OF LIFE MEASURED BY SHORT FORM 36 IS IMPROVED BY A 56-DAY TREATMENT WITH SARGRAMOSTIM IN ...
153 - OCCULT DYSPLASIA IN A LOCALIZED GIANT PSEUDOPOLYP IN CROHN'S COLITIS
154 - A 13-YEAR-OLD FEMALE ADOLESCENT WITH CONGENITAL IMMUNODEFICIENCY AND COLONIC STRICTURE
155 - GENDER DIFFERENCES EXIST IN THE GUT RESPONSE TO PROBIOTIC THERAPY
156 - CONCURRENT IMMUNOSUPPRESSION DEMONSTRATES NO SIGNIFICANT BENEFIT ON OUTCOMES IN PATIENTS REC...
157 - A PRELIMINARY STUDY ON THE EFFECT OF INFLIXIMAB ON BONE TURNOVER IN CROHN'S DISEASE
158 - RECTAL 5ASA FOR TREATMENT OF ACTIVE DISTAL ULCERATIVE COLITIS (UC): A COCHRANE COLLABORATION META...
159 - REFRACTORY CROHN'S DISEASE OF THE VULVA (MENDELSOHN-ROSENTHAL SYNDROME) TREATED WITH INFLIXIMAB...
160 - THE CROHN'S DISEASE SEVERITY SCORE (CDSS): A MORE USER-FRIENDLY ALTERNATIVE TO THE CROHN'S DISEASE...
161 - IN VIVO MEASUREMENT OF BUTYRATE METABOLISM IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS